Anzeige
Erschienen in:
01.09.2012 | Basic Science
Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2012
Einloggen, um Zugang zu erhaltenAbstract
Background
In this study, the effect of intravitreal injection of bevacizumab on choroidal blood vessels was examined in primate eyes.
Methods
Four Cynomolgus monkeys received an intravitreal injection of 1.25 mg bevacizumab. The eyes were enucleated on days 1, 4, 7 and 14. For each animal, one eye was embedded in paraffin whereas the other eye was embedded for electron microscopy. Seven untreated or PBS (phosphate buffered saline)-injected monkeys were used as controls.
Results
Thrombotic microangiopathy was found in the choriocapillaris and choroidal vessels of all eight injected eyes. Acute microangiopathy was characterized ultrastructurally as swelling of the endothelium, loss of fenestrations and complete collapse of the capillaries, and was commonly observed in bevacizumab-treated eyes. Quantitative analysis showed reduction of the lumina of the choriocapillaris in the eyes of three of the monkeys. Bevacizumab was frequently localized inside the blood vessels, often filling the entire breadth of the vessels, and formed clusters with blood cells. Death of photoreceptors occurred in two monkeys.
Conclusions
This study indicate that intravitreal injection of bevacizumab in monkeys induces activation of platelets, degranulation of thrombocytes and neutrophils, formation of immune complexes, thrombotic microangiopathy and alteration of the blood flow in choroidal vessels.